Immediate Impact
56 standout
Citing Papers
Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
2025 Standout
Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential
2025 Standout
Works of Tetsuo Ohashi being referenced
Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
2020
Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tetsuo Ohashi | 148 | 231 | 87 | 26 | 350 | |
| Qing Mao | 129 | 149 | 48 | 31 | 405 | |
| Hsiao-Yi Lin | 67 | 138 | 113 | 21 | 376 | |
| Mira Šćukanec‐Špoljar | 33 | 63 | 112 | 27 | 322 | |
| Takashi Nishiyama | 155 | 97 | 19 | 22 | 304 | |
| Xiaoyong Lu | 46 | 126 | 82 | 17 | 363 | |
| Chie Tomida | 54 | 185 | 20 | 20 | 383 | |
| Li Gao | 87 | 69 | 16 | 41 | 337 | |
| Xiaohua Liao | 44 | 77 | 10 | 26 | 370 | |
| Shigeyuki Miyamura | 41 | 136 | 10 | 17 | 340 | |
| Jinny Jeffery | 56 | 44 | 38 | 28 | 404 |
All Works
Login with ORCID to disown or claim papers
Loading papers...